
To view and download conference slides, please tap the presentation title. Not all presentations are available for download.

2021 Conference Slides
September 17–18, 2021
Cardiac Syndromes in Patients with Liver Disease • Marc Klapholz, MD, MBA
Heartburn: Are There Any Modern Diagnoses for GERD (or Still the Old Ones?) • Prakash Gyawali, MD
Esophageal Motility Disorders: An Overview • Prakash Gyawali, MD
New Advances Distinguished Lecturer 2021: Elimination of Viral Hepatitis • Su Wang, MD, MPH, FACP
Update on Hepatitis B in 2021 • Kimberly Brown, MD
Treatment Strategies for Hepatitis C • Paul Kwo, MD
Management of Patient with Compensated Cirrhosis • Patrick Kamath, MD
Pre-Transplant Evaluation: How to Proceed • Michael Schilsky, MD
Primary Biliary Cholangitis: New Treatment Options • Marlyn Mayo, MD
Hepatic Encephalopathy: An Update on Diagnosis and Management • Nancy Reau, MD
Hepatorenal Syndrome: To Treat or NOT to Treat? And How? • Nikolaos T. Pyrsopoulos, MD, PhD, MBA
Wilson’s Disease Overview • Michael Schilsky, MD
Liver Cancer: Still an Evolving Field! • Nikolaos T. Pyrsopoulos, MD, PhD, MBA
C. diffICULT (still!) • Sushil Ahlawat, MD
Colorectal Cancer Screening: How to Maximize the Potential • Sushil Ahlawat, MD
COVID-19 and Liver Disease: What Happened? • Nancy Reau, MD
To view and download conference slides, please tap the presentation title.

2022 Conference Slides
September 16–17, 2022
Hepatorenal Syndrome Treatment in the US Today • Nikolaos T. Pyrsopoulos, MD, PhD, MBA
Review of Eosinophilic Esophagitis • Seyedehsan Navabi, MD
New Treatment Innovations in Ulcerative Colitis and Crohn’s Disease • Stephen B. Hanauer, MD
New Advances in NASH in 2022 • David Kaplan, MD
Indeterminate Colitis: How to Approach? • Farzana Rashid, MD
How to Increase the Adenoma Detection Rate • Sushil Ahlawat, MD
New Advances Distinguished Lecturer 2022: Viral Hepatitis Elimination • Rajender Reddy, MD
Hepatitis B Cure: New Drugs, Novel Strategies • Jordan Feld, MD, MPH
Hepatitis C: What’s New? Is There Any Difficult to Treat Populations Nowadays? • Kimberly Brown, MD
Maximizing the Donor Potential for Liver Transplant • James Guarrera, MD
Minimally Invasive vs. Surgical Bariatric Interventions. Winner? • Kaveh Hajifathalian, MD
Advances in Pancreaticobiliary Endoscopy: Creating Alternate Solutions • Georgios Papachristou, MDH
Gastroparesis: Are We Moving on This Today? • Anthony J. Lembo, MD
NASH: Diagnostic and Prognostic Non-Invasive Tests • Nikolaos T. Pyrsopoulos, MD, PhD, MBA
Irritable Bowel Syndrome: New Management Approaches • Anthony J. Lembo, MD
Cirrhotic Cardiomyopathy: Does It Exist? • Marc Klapholz, MD
Liver Cancer: Still on the Rise or Plateaued? • Nikolaos T. Pyrsopoulos, MD, PhD, MBA
Hepatic Encephalopathy Overview • Paul Martin, MD
Wilson’s Disease: New Guidelines? • Nancy Reau, MD
Heartburn/GERD and H. Pylori • Ronnie Fass, MD
Alcoholic Liver Disease and COVID • Paul Martin, MD
Hemochromatosis: Is It the Liver’s Heavy Metal? • Nancy Reau, MD
C Difficult… • Sahil Khanna, MD
To view and download conference slides, please tap the presentation title.

2023 Conference Slides
September 29–30, 2023
Treatment Innovations in Esophagitis Management • Ronnie Fass, MD, MACG
Peptic Ulcer Disease – How To Treat Today? • Ronnie Fass, MD, MACG
What Is New in Hepatitis C • Paul Y. Kwo, MD
Hepatitis D • Paul Y. Kwo, MD
Noninvasive Colorectal Cancer Screening: Who and How? • Steven Itzkowitz, MD, FACP, FACG, AGAF
How to Increase the Adenoma Detection Rate (ADR)? • Steven Itzkowitz, MD, FACP, FACG, AGAF
IBD: Difficult to Treat Populations • Siobhan Proksell, MD
Hepatic Encephalopathy: New Innovations • Sammy Saab, MD, MPH, AGAF, FACG, FAASLD
New Advances in Upper and Lower Motility Disorders • Anthony Lembo, MD
What’s New Irritable Bowel Syndrome • Anthony Lembo, MD
Decompensated Cirrhosis: When Can We Use Albumin • Sammy Saab, MD, MPH, AGAF, FACG, FAASLD
Liver Transplant Evaluation: When to Start? • Nancy Reau, MD
Wilson Disease: What’s New in the 2022 Guidelines • Nancy Reau, MD